Europa · Agencias y tiempo real · Reuters US Markets

Swiss drug developer Windward Bio files for US IPO

Publicado por Reuters US Markets · Reino Unido hace 12 h

Windward Bio filed for a US initial public offering on Friday, becoming the latest drug developer seeking to capitalize on renewed ‌investor interest in biotech listings.

Leer el artículo completo en Reuters US Markets Inicie sesión para guardar

MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.reuters.com)

Swiss drug developer Windward Bio files for US IPO

También te puede interesar

UN secretary-general welcomes agreement on ceasefire in Alyoshki — office

New York stock market closes week lower

AI 'hallucinations' in court filings show signs of slowdown, but judges still sound alarms

Fastmarkets proposes calculated FOB South America lithium carbonate, hydroxide prices

Mark Cuban says AI hack agents are like cockroaches, but can be controlled

Ready for a French test?: Five questions for the ECB

Swiss drug developer Windward Bio files for US IPO

Compartir

También te puede interesar

UN secretary-general welcomes agreement on ceasefire in Alyoshki — office

New York stock market closes week lower

AI 'hallucinations' in court filings show signs of slowdown, but judges still sound alarms

Fastmarkets proposes calculated FOB South America lithium carbonate, hydroxide prices

Mark Cuban says AI hack agents are like cockroaches, but can be controlled

Ready for a French test?: Five questions for the ECB